Canada’s Largest Glycomics
In 2024, 5 of the top 10 selling drugs are glycosylated and have a combined revenue of $76 billion USD.
Global market for glycomics drugs to reach $257 billion USD by 2028.
Network Investigators
0
Funded Projects
0
Trained HQP
0
Network Partners
0
GlycoNet is advancing research, innovation, and training in glycomics to improve the quality of life of Canadians.
GlycoNet is a one-stop global destination focused on developing new carbohydrate-based drugs, vaccines and diagnostics, in collaboration with academic and industry organizations to address areas of unmet need through applied glycomics research. This national platform supports translational research, protection of intellectual property, novel drug development, company formation and training of a new generation of glyco-scientists and entrepreneurs. The network includes over 190 researchers across Canada who focus on cancer, chronic diseases, infectious diseases, and neurodegenerative diseases.
GlycoNet is funded by the Government of Canada through the Strategic Science Fund (2024-2029).
GlycoNet Integrated Services
GlycoNet Integrated Services (GIS) is Canada’s only and one of the world’s leading glycomics platforms. As a core facility centralized at GlycoNet and housed at research institutions across Canada, our experts are at the forefront of glycomics research and are continually improving, expanding, and optimizing methods and technologies.
GIS is supported in part by the Canada Foundation for Innovation’s Major Science Initiatives Fund (2023-2029) and Genome Canada’s Technology Development Program (2023-2026).
Services
- Glycan–Ligand Screening and Discovery
- Glycan Analysis
- Carbohydrate Synthesis
- Drug Discovery & High-Throughput Screening (HTS)
- Molecular Glycobiology & Glycoengineering
Our services, instruments, technologies and professional services are available to all researchers, from Canada and abroad, across academic, private, and government sectors. The facility’s scientific and technical personnel provides high-quality, high-throughput, and competitively priced products and services to all of its clients.
CGS 2026
Join us for the 9th Canadian Glycomics Symposium, taking place in Canmore, Alberta during May 12-14, 2026. Registration now open.
Call for Abstracts open until February 28, 2026.
Featured Reports
Glycomics: The New Frontier in Bioinnovation
Why glycomics, the study of sugars on cells, is at the centre of a new surge of scientific and industry interest.
10 Year Impact Report
Celebrating a decade of Canadian glycomics innovation and impact.
Latest News
GlycoNet Investigator receives 2026 Horace S. Isbell Award
Congratulations to Dr. Matthew Macauley on receiving the 2026 Horace S. Isbell Award
Read More
Sugar-based vaccine against bacterial diarrhea shows promise in Phase 1 trial
A step closer to a vaccine for Campylobacter jejuni, a major global cause of diarrheal illness.
Read More
32nd International Carbohydrate Symposium
GlycoNet will be attending the 32nd International Carbohydrate Symposium (ICS 2026), taking place July 5–9, 2026, in Bratislava, Slovakia.
Read More
GlycoNet community member honoured with Roy L. Whistler International Award in Carbohydrate Chemistry
Congratulations to Dr. Todd Lowary on this recognition from the International Carbohydrate Organization.
Read More
